medicare coverage glp-1 drugs New GLP-1 Weight-Loss Drug Demonstration Begins

There are two GLP-1 pills: Wegovy (semaglutide) was the first GLP-1 pill approved for weight loss in December 2025

Because its a stimulant, the phentermine label warns about increases in blood pressure, insomnia if taken late in the day, and its contraindicated in people with a history of cardiovascular disease, uncontrolled hypertension, hyperthyroidism, glaucoma, agitated states, or a history of drug abuse

Holmes gives all her patients before they stop taking a GLP-1 like Wegovy, Mounjaro, or Ozempic: "Stopping the medication does not mean you have failed

Everything you need to succeed is right here

When researchers delete the GLP-1 receptors from the brains of mice, the drug loses its appetite-suppressing effects, says Krashes